Neurodegenerative Disease Research Proteomic Tender - 141244299

Procurement Summary

Country: USA

Summary: Neurodegenerative Disease Research Proteomic Analysis Services

Deadline: 27 May 2026

Posting Date: 14 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 141244299

Document Ref. No.: NIH-NOI-26-PCA-NIA-01589

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

SYNOPSIS WORKSHEET
NIH-NOI-26-PCA-NIA-01589
NAICS 541380 - TESTING LABORATORIES AND SERVICES
PSC Q301 - Reference Laboratory Testing
This is a Notice of Intent (NOI). This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a sole source, firm-fixed price purchase order under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 13.106-1(b) and 13.501(a)- Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements and is not a request for quotes.
The National Institutes of Health (NIH) intends to negotiate on an other than full and open competition to the maximum extent practicable consistent with the agency-s minimum needs. For this acquisition, however, full and open competition is not contemplated. The acquisition is being conducted under the authority of 41 U.S.C. § 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. Based on the market research conducted, Banner Sun Health is the only known source capable of providing the required NULISA protein analysis services together with the established and validated quality control (QC) bridging cohort necessary to meet the Government-s minimum needs. The Government-s requirement is not limited to routine NULISA assay execution. It includes the ability to support:
Longitudinal analytical consistency across assay runs, batches, and study periods;
Assessment and correction of analytical drift;
Normalization of datasets generated over time; and
Harmonization of current project data with future datasets and external collaborators.
Banner Sun Health is uniquely qualified because it already maintains a dedicated, validated, matrix-matched, dynamic-range-qualified, and biobanked NULISA QC bridging cohort designed specif...
Notice ID: nih-noi-26-pca-nia-01589

Department/Ind. Agency: health and human services, department of

Sub-tier: national institutes of health

Office: national institutes of health olao

Product Service Code: q301 - reference laboratory testing

NAICS Code: 541380 - Testing Laboratories and Services

Inactive Dates: jun 11, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice

Documents.zip